We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,974 results
  1. Deucravacitinib in plaque psoriasis: a profile of its use

    Deucravacitinib (SOTYKTU™) is a tyrosine kinase 2 (TYK2) inhibitor that expands the availability of effective oral treatments for the management of...

    Article 01 November 2023
  2. Tapinarof cream 1% in plaque psoriasis: a profile of its use

    Tapinarof (VTAMA ® ) cream 1%, a topical, non-steroidal, aryl hydrocarbon receptor agonist, presents a valuable addition to the therapy options for...

    Article 27 July 2023
  3. Spesolimab in generalised pustular psoriasis flares: a profile of its use

    Spesolimab (Spevigo ® ) is a promising new treatment for generalised pustular psoriasis (GPP) flares. GPP is a rare and life-threatening...

    Article 02 December 2023
  4. Novel Psoriasis Treatment: Development and Evaluation of a Thermo-Sensitive Pro-Penetrating Hydrogel Based on Coptis chinensis and Phellodendron amurense

    Psoriasis is a chronic papulosquamous skin disease whose current treatments have severe side effects, which limits their long-term application....

    Jiangtao Su, Yuxuan Zhang, ... Yuchen Hu in Revista Brasileira de Farmacognosia
    Article 15 August 2023
  5. Treat psoriasis with traditional and novel topical therapies

    The mainstay topical treatments for psoriasis are corticosteroids and/or vitamin D analogues, with retinoids, calcineurin inhibitors, salicylic acid...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 05 August 2022
  6. Several approved biologic agents are now available to treat paediatric plaque psoriasis

    Off-label treatments are widely used in the treatment of paediatric psoriasis, which are prescribed on the basis of efficacy and safety data derived...

    Esther S. Kim, Arnold Lee in Drugs & Therapy Perspectives
    Article 17 February 2022
  7. Pruritus in psoriasis and atopic dermatitis: current treatments and new perspectives

    Psoriasis and atopic dermatitis (AD) are two common chronic inflammatory skin diseases. Although showing different etiology and clinical...

    Shirin Kahremany, Lukas Hofmann, ... Guy Cohen in Pharmacological Reports
    Article 18 January 2021
  8. Psoriatic arthritis: the role of the nonphysician clinician in the diagnosis and treatment of patients with psoriasis

    Psoriatic arthritis is a clinically heterogeneous, chronic, and progressive disease that develops in up to 30% of patients with psoriasis and is...

    Michael D. Overcash, Christopher Chillura, ... Clint Blankenship in Drugs & Therapy Perspectives
    Article Open access 04 March 2021
  9. Ceramides and sphingolipids are more than simple building blocks

    Ceramides and sphingolipids are long chain fatty acids, which are components of the stratum corneum layer of the skin. The composition of ceramides,...

    Article 24 June 2022
  10. Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases

    Disruption of the skin barrier and immunity has been associated with several skin diseases, namely atopic dermatitis (AD), psoriasis, and acne....

    Mahika Joshi, Priyanka Hiremath, ... Jayesh Mudgal in Pharmacological Reports
    Article Open access 06 September 2023
  11. Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability

    To date, numerous biosimilars are available in Europe and the practice of switching between originator and biosimilar or between two different...

    Ruggero Lasala, Paolo Abrate, ... Fiorenzo Santoleri in Therapeutic Innovation & Regulatory Science
    Article 02 November 2022
  12. Modulation of allergic contact dermatitis via gut microbiota modified by diet, vitamins, probiotics, prebiotics, and antibiotics

    Allergic contact dermatitis is one of the most common recorded occupational diseases. There are many different substances that the skin comes into...

    Aneta Kiecka, Barbara Macura, Marian Szczepanik in Pharmacological Reports
    Article Open access 02 February 2023
  13. Dimethyl Fumarate Ameliorates the Amyotrophic Lateral Sclerosis Symptoms in Tg-SOD1G93A Mice

    Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative disorder that affects motor neurons and has limited therapeutic...

    Georgios Angelis, Anastasia S. Tsingotjidou, ... Georgios Pampalakis in Pharmaceutical Chemistry Journal
    Article 01 May 2024
  14. Journey from Serendipity to Biologics

    The world today is largely focused on biologics-based treatment for many diseases as it is a very specific way to treat any disease and also happens...

    Nutan Rao, Riddhi Kini, ... Rishika Amin in Pharmaceutical Chemistry Journal
    Article 04 March 2022
  15. Guselkumab in psoriatic arthritis: a profile of its use

    Guselkumab (TREMFYA ® ), a fully human immunoglobulin G1λ (IgG1λ) monoclonal antibody that selectively targets interleukin (IL)-23, is an effective and...

    Yvette N. Lamb in Drugs & Therapy Perspectives
    Article Open access 03 June 2021
  16. Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis

    A wide range of drugs has been associated with the development of acute generalised exanthematous pustulosis (AGEP). Although AGEP is rare and...

    Esther S. Kim, Connie Kang in Drugs & Therapy Perspectives
    Article 28 April 2024
  17. Validation of a Test System Based on Enzyme-Linked Immunosorbent Assay for the Evaluation of Etanercept Pharmacokinetics in Patients

    A test system based on solid-phase ELISA was developed for the assay of etanercept patients’ in biological fluids for the purpose of evaluating the...

    V. V. Pisarev, A. V. Ivanov in Pharmaceutical Chemistry Journal
    Article 01 October 2023
  18. mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment

    Background

    Psoriasis is a multifactorial autoimmune disease, which underlies the abnormalities of the apoptotic process. In cases of psoriasis and...

    Agata Krawczyk, Barbara Strzałka-Mrozik, ... Joanna Gola in Pharmacological Reports
    Article Open access 02 March 2020
  19. Various Formulations of Glycyrrhizic Acid and the Possibility of Their Use in Virus-Associated and Inflammatory Diseases

    Pharmaceuticals containing glycyrrhizic acid that exhibit a pleiotropic effect and reduce the risk of progression of cervical lesions associated with...

    M. S. Filimonova, N. L. Shimanovsky in Pharmaceutical Chemistry Journal
    Article 28 July 2023
Did you find what you were looking for? Share feedback.